Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01147497 · ClinicalTrials.gov registry record · NA
Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women
A NA study, sponsored by Emory University.
- Completed
- Registry status
- NA
- Development phase
- 78
- Enrollment target
NCT01147497: Completed NA study, sponsored by Emory University.
NCT01147497 is a NA study that has completed, run by Emory University. The registered enrollment target is 78 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01147497, a NA study, has completed, sponsored by Emory University.
- COMPLETED
- Registry status
- NA
- Development phase
- 78 participants
- Enrollment target
Study Summary
Because of misoprostol's known ability to cause cervical dilation, some family planning providers give their patients a dose of this drug prior to insertion. The goal of this study is to evaluate whether misoprostol prior to IUD insertion in nulliparous women eases insertion and decreases pain.
Primary Outcome
The visual analogue scale for perceived ease ranges from 0 (most ease) to 100 (most difficult).
Interventions
- DRUG Placebo
- DRUG Misoprostol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 78 participants |
| Start Date | 2010-06 |
| Est. Completion | 2011-09 |
| Phase | NA |
What the finished NCT01147497 record still lists
NCT01147497 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 78 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01147497 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01147497 about?
NCT01147497 is a clinical study titled "Misoprostol Prior to Intrauterine Device (IUD) Insertion in Nulliparous Women". Because of misoprostol's known ability to cause cervical dilation, some family planning providers give their patients a dose of this drug prior to insertion. The goal of this study is to evaluate whether misoprostol prior to IUD insertion in nulliparous women eases insertion and decreases pain.
What is the current status of trial NCT01147497?
This trial is currently completed. It is a NA study. The enrollment target is 78 participants. The study started on 2010-06. Estimated completion is 2011-09.
What interventions are being tested in trial NCT01147497?
The interventions under investigation include: Placebo (DRUG), Misoprostol (DRUG).
Who is sponsoring clinical trial NCT01147497?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01147497's enrollment target sits among peer trials
78 1060th of 2000 higher than 939 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02397668 · 78 participants · NA
CorMatrix Cor TRICUSPID ECM Valve Replacement Study
- NCT03321656 · 78 participants · Phase 2
Impact of Envarsus XR® on Kidney Biopsy Subclinical Rejection and Blood Immunologic Profile
- NCT03687814 · 78 participants · NA
Low FODMAP Plus PEG 3350 for the Treatment of Patients with Irritable Bowel Syndrome-Constipation
- NCT04018872 · 78 participants · Phase 2
Evaluating the Effect of Itraconazole on Pathologic Complete Response Rates in Esophageal Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia